About Us

We are an innovative company developing RNA-targeted therapeutics focussed to improve the quality of life for people with Duchenne muscular dystrophy.

Sutura Therapeutics has developed proprietary RNA-targeting gene therapeutics and seeks to provide novel treatment regimens for medical conditions with unmet clinical needs. The platform technology has extremely broad clinical applications that can have a profound societal impact within the healthcare arena. 

FIND OUT MORE

Pipelines

Our current Pipeline Developments focus on addressing the spectrum of pathological changes in Duchenne muscular dystrophy.

FIND OUT MORE

Get in touch

General Enquiries

info@suturatherapeutics.com
+1 (649) 441 6731 

Biotech & Partnerships

partners@suturatherapeutics.com
+44 (0) 7881 955 716

Investors

investors@suturatherapeutics.com
+33 (607) 936 731

Keep Informed

Sign up for future updates

Thank you